AlloVirListed
allovir.combiotech_life_sciences
AlloVir is a biopharmaceutical company focused on developing treatments for viral infections. Its website is allovir.com. The company is involved in clinical-stage therapies.
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
AlloVir is a biopharmaceutical company focused on developing treatments for viral infections. Its website is allovir.com. The company is involved in clinical-stage therapies.
IGM Biosciences is a clinical-stage biotechnology company focused on developing engineered IgM antibodies for the treatment of autoimmune and inflammatory diseases. The company le…
Saluda Medical is focused on pioneering sensing technology to develop a new generation of neuromodulation therapies aimed at disrupting pain management.
Repare Therapeutics is a clinical-stage precision oncology company focused on developing targeted therapies that address genetic alterations in tumors using its proprietary SNIPRx…
ArcherDX provides software and databases for genomic analysis, particularly focusing on gene fusion data relevant to cancer research.
Augmedix provides AI-centric solutions for human-centric medicine, focusing on EHR documentation to enhance the doctor-patient relationship.
BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. The company focuses on transforming cancer treatment th…
Redx is a clinical-stage biotechnology company focused on the development of novel, small molecule, targeted medicines for the treatment of fibrotic disease.
Abcuro is developing breakthrough therapies for autoimmune diseases and cancer, focusing on selective targeting of highly cytotoxic T cells. Their lead product candidate, ulviprub…
Neuron23 is focused on developing precision medicine approaches to improve the lives of people with Parkinson’s disease, leveraging data science and human genetics.
Electra Therapeutics is pioneering a new class of precision medicines focused on Signal Regulatory Protein (SIRP)-directed therapies aimed at improving outcomes for patients with…
Ambrosia Biosciences is a drug discovery company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders. The company integrates cryo…
Obsidian Therapeutics is pioneering engineered TIL cell therapies using its proprietary cytoDRiVE® platform to improve outcomes for patients with solid tumor malignancies.
Absci is a generative AI drug creation company on a mission to create better biologics for patients, faster. The company leverages its Integrated Drug Creation™ Platform to design…